Stayble Therapeutics
Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a Master’s in economics and Venture Creation from Chalmers University of Technology.
Stayble Therapeutics
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.